Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-U.S. to send 4 mln doses of AstraZeneca vaccine to Mexico, Canada in loan deal -official

Thu, 18th Mar 2021 16:59

(Adds Psaki comment)

By Jeff Mason

WASHINGTON, March 18 (Reuters) - The United States plans to
send roughly 4 million doses of AstraZeneca's COVID-19 vaccine
that it is not using to Mexico and Canada in loan deals with the
two countries, an administration official told Reuters on
Thursday.

Mexico will receive 2.5 million doses of the vaccine and
Canada is to receive 1.5 million doses, the official said.

"We're lending a portion of our releasable doses of
AstraZeneca vaccine," the official said on condition of
anonymity. "We only put the virus behind us if we're helping our
global partners."

White House spokeswoman Jen Psaki confirmed the plan, first
reported by Reuters, to send doses to Mexico and Canada. "It is
not fully finalized yet but it is our aim," she told a daily
briefing.

The Biden administration has come under pressure from allies
worldwide to share vaccines, particularly from AstraZeneca,
which is authorized for use in other countries but not yet in
the United States.

AstraZeneca has millions of doses made in a U.S.
facility, and has said that it would have 30 million shots ready
at the beginning of April. The company's shares rose slightly on
the news.

The deal to share the vaccine, which is still being
finalized, does not affect President Joe Biden's plans to have
vaccine available for all adults in the United States by the end
of May, the official said. It does not reduce the supply of
available vaccine in the United States.

The deal is likely to be announced publicly in the coming
days.

Two officials said the vaccine would be delivered in "short
order" once the deal was completed, but they declined to give a
more specific timetable.

The "releasable" vaccines are ready to be used once they
arrive. Under the deal, the United States will share doses with
Mexico and Canada now with the understanding that they will pay
the United States back with doses in return. The official said
that would take place later this year.

The United States had no plans to share the vaccine with
other countries at this time, he said.

"They are our neighbors, they are our partners," the
official said about Mexico and Canada. Mexican President Andres
Manuel Lopez Obrador had requested the vaccine previously. The
official said the countries were in touch about the vaccine
loan. "We've been working through the diplomatic channels," he
said.

Reports of blood disorders have prompted more than a dozen
nations to suspend use of AstraZeneca's vaccine but on Thursday
the EU's drug watchdog said that after an investigation it is
still convinced the benefits of that vaccine outweigh the risks.

Biden has said if the United States has a surplus of
vaccine, it will share it with the rest of the world. The White
House has focused on vaccinating people in the United States,
which has seen more than 530,000 people die from virus.

The country was getting prepared to roll out the AstraZeneca
vaccine domestically if it gets authorization from the U.S. Food
and Drug Administration, the official said.

The official noted that the United States has pledged $4
billion to the COVAX vaccine facility that aims to deliver
coronavirus vaccines to poor countries.

The United States does not need the AstraZeneca shots to
meet its target of having enough doses for all U.S. adults by
the end of May.

The three authorized vaccine makers – Pfizer Inc/BioNTech
SE, Moderna Inc, and Johnson & Johnson – have promised to
deliver nearly 500 million doses to the United States by then.
(Reporting by Jeff Mason; additional reporting by Trevor
Hunnicutt and Caroline Humer; Editing by Heather Timmons and
Alistair Bell)

More News
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.